Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

CUSIP: 603170101

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+2,096,030
Put/Call ratio
105%
SEC-reported price per share
$27.09
Number of holders
213
Value change
-$6,333,024
Number of buys
123
Open additional details 1 more signal available
Number of sells
89
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,235,030

Security key

603170101

Report period

Q1 2026

Institutions

213

Top holders

10

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Catalys Pacific Fund, LP
Disclosed value leader
Catalys Pacific, LLC
Comparable rows
15/15
Latest evidence
27 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Catalys Pacific Fund, LP Showing 1-6 of 15 holder rows.

Quick read

Catalys Pacific Fund, LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Catalys Pacific Fund, LP's linked filing trail.
Comparable ownership Top 5
Catalys Pacific Fund, LP 10%
RA CAPITAL MANAGEMENT, L.P. 9.9%
Samsara BioCapital, L.P. 8.2%
FMR LLC 6.3%
BlackRock, Inc. 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Catalys Pacific Fund, LP
13D/G
10%
$267,051,367
8,002,738 shares
-$32,576,328 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G 3/4/5
Company · Director
9.9%
from 13D/G
$265,778,888
7,323,750 shares
31 Dec 2025
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
8.2%
$85,419,771
6,346,194 shares
+$8,209,106 04 Sep 2025
FMR LLC
13F 13D/G
Company
6.3%
from 13D/G
$183,537,002
5,057,509 shares
31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
5.2%
from 13D/G
$157,051,434
4,327,678 shares
31 Dec 2025
Andera Partners
13F 13D/G
Company
4.2%
from 13D/G
$57,770,668
1,591,917 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
213
Shares
90,325,196
Rows available
213
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
213
Q1 2026 holders
213
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .